Split History
ETFs Holding PPHM »    PPHM Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Peregrine Pharmaceuticals is a biopharmaceutical company, focused on manufacturing pharmaceutical products through its contract manufacturing business, and licensing its immunotherapy product through its research and development business. Co.'s segments are: Avid, which is Co.'s contract development and manufacturing organization business, engaged in providing current good manufacturing practices services from cell line development to commercial biomanufacturing of molecules; and Peregrine, which is Co.'s research and development business, engaged in developing therapeutics designed to fight cancer by reversing the immunosuppressive environment that tumors establish in order to proliferate. According to our PPHM split history records, PPHM has had 1 split.
PPHM split history picture
PPHM (PPHM) has 1 split in our PPHM split history database. The split for PPHM took place on July 10, 2017. This was a 1 for 7 reverse split, meaning for each 7 shares of PPHM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.

When a company such as PPHM conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the PPHM split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PPHM shares, starting with a $10,000 purchase of PPHM, presented on a split-history-adjusted basis factoring in the complete PPHM split history. PPHM split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/01/2012
End date: 01/05/2018
Start price/share: $6.02
End price/share: $4.22
Dividends collected/share: $0.00
Total return: -29.90%
Average Annual Total Return: -6.52%
Starting investment: $10,000.00
Ending investment: $7,011.52
Years: 5.27
Date Ratio
07/10/20171 for 7
PPHM is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

PRAN Split History
PRGO Split History
PRPO Split History
PRSN Split History
PRTK Split History
PRXL Split History
PSTI Split History
PSTV Split History
PTE Split History
PTIE Split History

Email EnvelopeFree PPHM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PPHM Insider Buying

PPHM Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.